Today's Hours: 12:00pm - 8:00pm

Search

Did You Mean:

Search Results

  • Book
    Neeta Raj Sharma, Karupppasamy Subburaj, Kamalpreet Sandhu, Vivek Sharma, editors.
    Summary: This book focuses on applications of three-dimensional (3D) printing in healthcare. It first describes a range of biomaterials, including their physicochemical and biological properties. It then reviews the current state of the art in bioprinting techniques and the potential application of bioprinting, computer-aided additive manufacturing of cells, tissues, and scaffolds to create organs in regenerative medicine. Further, it discusses the orthopedic applications of 3D printing in the design and fabrication of dental implants, and the use of 3D bioprinting in oral and maxillofacial surgery and in tissue and organ engineering. Lastly, the book examines the 3D printing technologies that are used for the fabrication of the drug delivery system. It also explores the current challenges and the future of 3D bioprinting in medical sciences, as well as the market demand.

    Contents:
    Chapter 1. Introduction to Biomaterials
    Chapter 2. Different approaches used for conversion of biomaterials to feedstock
    Chapter 3. Bioprinting
    Chapter 4. 3D Printed Implants for Joint Replacement
    Chapter 5. Design of Patient-Specific Maxillofacial Implants and Guides
    Chapter 6. Design and Development of surgical guide for dental implant surgery
    Chapter 7. Three Dimensional printed drugs and related technology : a potential review
    Chapter 8. Product Sustainability Assessment
    Chapter 9. Successful Stories of 3D Printing in Healthcare Applications: A Brief Review.
    Digital Access Springer 2021
  • Article
    Hurst JW, King SB, Logue RB, Hatcher CR, Jones EL, Craver JM, Douglas JS, Franch RH, Dorney ER, Cobbs BW, Robinson PH, Clements SD, Kaplan JA, Bradford JM.
    Am J Cardiol. 1978 Aug;42(2):308-29.
    The value of coronary bypass surgery has been studied carefully during the last decade. Four methods, none perfect, have been used to compare the results of such surgery with the results of medical therapy. New data are likely to be merely supportive rather than the outcome of a definitive study with a new and a acceptable experimental design. It is therefore time to analyze the available data in light of the treacherousness of the disease and to determine if a clear trend is evident. There appears to be sufficient evidence to state that properly performed coronary bypass surgery will increase coronary blood flow and relieve angina pectoris in 90 percent of patients; total relief of angina can be expected in 60 percent and partial relief in 30 percent. Compared with modern medical therapy, properly performed coronary bypass surgery appears to prolong the life of patients who have obstruction of the left main coronary artery or triple or double vessel disease. There is not adequate evidence to state that the procedure will prolong the life of patients with single vessel obstruction. However, patients with single vessel obstruction and unacceptable angina pectoris should be considered for bypass surgery (especially patients with obstruction of the left anterior descending coronary artery). In practice, at Emory University Hospital, Atlanta, bypass surgery is recommended for young people with few symptoms if compelling obstructing lesions are present and in older patients only if their symptoms require it. Medical therapy is given before and after bypass surgery. When bypass surgery is performed in an excellent fashion (operative risk 1 percent) a great deal of "controversy" about this problem vanishes.
    Digital Access Access Options